Benvenuti M, Albanese L, Pagliara L
Minerva Med. 1983 Jun 23;74(26):1563-8.
Fifty outpatients suffering from rheumatoid disorders were treated with proglumetacin. Efficacy was classified as "good" or "very good" in 80% of cases. Besides this considerable efficacy, a tolerance classified as "good" or "very good" was observed in 86% of patients.
五十名类风湿性疾病门诊患者接受了丙谷美辛治疗。80%的病例疗效被归类为“良好”或“非常好”。除了这种显著疗效外，86%的患者耐受性被归类为“良好”或“非常好”。
